|
ZNF879 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87935000000028E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.631300E-04 |
| Normal-vs-Stage2 |
1.410160E-02 |
| Normal-vs-Stage3 |
2.80169999999913E-06 |
| Normal-vs-Stage4 |
5.90809999999609E-05 |
| Stage1-vs-Stage2 |
8.780800E-01 |
| Stage1-vs-Stage3 |
2.757600E-02 |
| Stage1-vs-Stage4 |
8.168200E-02 |
| Stage2-vs-Stage3 |
9.842400E-02 |
| Stage2-vs-Stage4 |
1.198790E-01 |
| Stage3-vs-Stage4 |
9.587600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21409999999755E-05 |
| Normal-vs-AfricanAmerican |
2.663600E-02 |
| Normal-vs-Asian |
1.008300E-02 |
| Caucasian-vs-AfricanAmerican |
8.024200E-01 |
| Caucasian-vs-Asian |
2.155400E-01 |
| AfricanAmerican-vs-Asian |
6.329600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.213800E-04 |
| Normal-vs-Female |
1.81360000000019E-05 |
| Male-vs-Female |
3.860800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.396000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.169900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.971600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.266400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.625000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.104600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.101600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.625400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.802000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.599200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.194000E-04 |
| Classical-VS-Follicular |
7.145800E-01 |
| Classical-VS-Other |
3.619400E-01 |
| Classical-VS-Normal |
1.356360E-04 |
| Tall-VS-Follicular |
1.704140E-03 |
| Tall-VS-Other |
8.878000E-02 |
| Tall-VS-Normal |
3.76200000040683E-07 |
| Follicular-VS-Other |
4.950000E-01 |
| Follicular-VS-Normal |
6.475700E-03 |
| Other-VS-Normal |
5.620200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.179650E-03 |
| Normal-vs-N1 |
2.36179999999475E-05 |
| N0-vs-N1 |
3.356300E-02 |
|
|
